Compass Pathways reports 6-month data from phase 3 TRD trial
Compass Pathways reports 6-month data from phase 3 TRD trial
Compass Pathways reports 6-month data from phase 3 TRD trial
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.